APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease
- 30 September 2004
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 176 (1), 165-172
- https://doi.org/10.1016/j.atherosclerosis.2004.04.024
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart diseaseJournal of Lipid Research, 2004
- Structure and Interfacial Properties of Human Apolipoprotein A-VJournal of Biological Chemistry, 2003
- A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemiaHuman Molecular Genetics, 2003
- Apolipoprotein AIV Gene Variant S347 Is Associated With Increased Risk of Coronary Heart Disease and Lower Plasma Apolipoprotein AIV LevelsCirculation Research, 2003
- Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildrenHuman Genetics, 2002
- Apolipoprotein A-VOnline Journal of Public Health Informatics, 2001
- An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative SequencingScience, 2001
- Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factorAtherosclerosis, 2001
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991